Detalhe da pesquisa
1.
Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of Myelofibrosis.
Br J Haematol
; 199(4): 529-538, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36089912
2.
Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma.
Ann Hematol
; 100(7): 1769-1778, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33885924
3.
Ibrutinib and R-GemOx in patients with relapsed or refractory diffuse large B-cell lymphoma of non-GCB type: Phase II clinical trial of the Spanish GELTAMO group.
Clin Cancer Res
; 2024 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38900037
4.
Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis.
Hemasphere
; 7(1): e818, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36570691
5.
Cost-minimisation analysis of chronic lymphocytic leukemia in Spain in the era of oral targeted therapies.
Farm Hosp
; 46(2): 72-79, 2022 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35379098
6.
Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study).
Clin Lymphoma Myeloma Leuk
; 21(12): e985-e999, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34511320
7.
Treatment with daratumumab in patients with relapsed/refractory AL amyloidosis: a multicentric retrospective study and review of the literature.
Amyloid
; 27(3): 163-167, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32106714
8.
Early Prediction of Subsequent Molecular Response to Nilotinib in Patients with Chronic Myeloid Leukemia: Comparison of the Quantification of BCR-ABL1 Ratios Using ABL1 or GUSB Control Genes.
J Mol Diagn
; 22(10): 1217-1224, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32688056
9.
Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase.
J Cancer Res Clin Oncol
; 144(1): 187-188, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29063181
10.
Análisis de minimización de costes de la leucemia linfocítica crónica en España en la era de las terapias orales dirigidas / Cost-minimisation analysis of chronic lymphocytic leukemia in Spain in the era of oral targeted therapies
Farm. hosp
; 46(2): 1-8, Mar-Abr 2022. tab, graf
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-203858
11.
An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase.
J Cancer Res Clin Oncol
; 143(10): 2059-2066, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28551768
12.
Update of the Grupo Español de Leucemia Linfocítica Crónica clinical guidelines of the management of chronic lymphocytic leukemia. / Actualización de las guías nacionales de consenso del Grupo Español de Leucemia Linfocítica Crónica para el tratamiento y seguimiento de la leucemia linfocítica crónica.
Med Clin (Barc)
; 148(8): 381.e1-381.e9, 2017 Apr 21.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-28236475
13.
Further psychometric validation of the GAH scale: Responsiveness and effect size.
J Geriatr Oncol
; 8(3): 211-215, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28017687
14.
Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis.
Leukemia
; 35(1): 245-249, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32203144
15.
Actualización de las guías nacionales de consenso del Grupo Español de Leucemia Linfocítica Crónica para el tratamiento y seguimiento de la leucemia linfocítica crónica / Update of the Grupo Español de Leucemia Linfocítica Crónica clinical guidelines of the management of chronic lymphocytic leukemia
Med. clín (Ed. impr.)
; 148(8): 381.e1-381.e9, abr. 2017. tab, graf
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-161625